CRA was retained by a non-profit organization to provide an expert opinion on damages in a breach of contract arbitration concerning a funding agreement relating to a cystic fibrosis therapy. CRA quantified the amount owed to the plaintiff in connection with a milestone payment tied to the value of technology developed under the funding agreement. CRA provided a report on economic damages as well as hearing testimony.
Smallest saleable patent-practicing unit in life sciences disputes
In this article titled “Smallest saleable patent-practicing unit in life sciences disputes,” author Erin McDermott examines methods for calculating damages in...